Overview
Hans-josef Feistritzer practices in Leipzig, Germany. Feistritzer is rated as an Elite expert by MediFind in the treatment of Heart Attack. Their top areas of expertise are Heart Attack, Cardiogenic Shock, Aortic Valve Stenosis, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).
Their clinical research consists of co-authoring 107 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 84 articles in the study of Heart Attack.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Heart AttackFeistritzer isElite. Learn about Heart Attack.
- Distinguished
- Cardiogenic ShockFeistritzer isDistinguished. Learn about Cardiogenic Shock.
- Advanced
- Percutaneous Coronary Intervention (PCI)
- Transcatheter Aortic Valve Replacement (TAVR)
- Experienced
- Acute Coronary SyndromeFeistritzer isExperienced. Learn about Acute Coronary Syndrome.
- AngioplastyFeistritzer isExperienced. Learn about Angioplasty.
- Aortic Valve StenosisFeistritzer isExperienced. Learn about Aortic Valve Stenosis.
- Coronary Heart DiseaseFeistritzer isExperienced. Learn about Coronary Heart Disease.
- Heart FailureFeistritzer isExperienced. Learn about Heart Failure.
- Heart TumorFeistritzer isExperienced. Learn about Heart Tumor.